Skip to main content

Table 4 Shows the hemodynamics, and blood gases during in vivo early phase and late phase, and during ex vivo lung perfusion (EVLP) in the start and of early phase and late phase

From: A new way of monitoring mechanical ventilation by measurement of particle flow from the airways using Pexa method in vivo and during ex vivo lung perfusion in DCD lung transplantation

  In vivo In vivo EVLP EVLP EVLP EVLP
Early phase Late phase Early phase start Early phase end Late phase start Late phase end
Heart rate (bmp) 91 ± 21 92 ± 18     
Systolic blood pressure (mmHg) 89 ± 18 88 ± 19     
Diastolic blood pressure (mmHg) 65 ± 16 67 ± 15     
Temperature (°C) 36.8 ± 0.9 36.8 ± 0.9 37 ± 0.1 37 ± 0.1 37 ± 0.1 37 ± 0.1
SpO2 (%) 99 ± 1.0 99 ± 1.0 99 ± 1 99 ± 1 99 ± 1 99 ± 1
pH 7.5 ± 0.2 7.5 ± 0.2 7.5 ± 0.1 7.5 ± 0.2 7.5 ± 0.1 7.5 ± 0.2
Po2 (mmHg) 30.9 ± 0.7 31.2 ± 0.9 64.8 ± 6.0 65.6 ± 5.0 67.7 ± 1.8 63.3 ± 2.3
Pco2 (mmHg) 3.87 ± 0.23 3.86 ± 0.24 2.9 ± 0.3 3.0 ± 0.4 3.2 ± 0.6 3.1 ± 0.9
FiO2 0.5 0.5 1.0 1.0 1.0 1.0
Flowrate (L/min), i.e., cardiac output (CO)    3.5 ± 0.1 3.5 ± 0.1 3.4 ± 0.5 2.5 ± 0.5
Pulmonary pressure (mmHg)    12 ± 0.5 11 ± 0.4 15 ± 1.5 19 ± 1.0
Left atrium pressure (mmHg)    0 ± 0 0 ± 0 0 ± 0 0 ± 0
Pulmonary vascular resistance (PVR)    273 ± 12 251 ± 2 361 ± 23 623 ± 36